CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,383,812
- in 18 filings, $13.4M under 10b5-1 plans
Net −$32,383,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-16 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $8.46 | $125K | 427,220 |
| 2026-04-16 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −19,060 | $14.18 | $270K | 408,160 |
| 2026-04-16 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 148,770 | ||
| 2026-04-15 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $8.46 | $125K | 431,558 |
| 2026-04-15 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −19,060 | $14.61 | $278K | 412,498 |
| 2026-04-15 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 163,492 | ||
| 2026-04-14 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $8.46 | $125K | 435,896 |
| 2026-04-14 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −19,060 | $14.56 | $278K | 416,836 |
| 2026-04-14 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 178,214 | ||
| 2026-04-13 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +8,109 | $7.27 | $59K | 433,621 |
| 2026-04-13 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +6,613 | $8.46 | $56K | 440,234 |
| 2026-04-13 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −15,722 | $12.95 | $204K | 424,512 |
| 2026-04-13 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −3,338 | $14.08 | $47K | 421,174 |
| 2026-04-13 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −8,109 | 0 | ||
| 2026-04-13 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −6,613 | 192,936 | ||
| 2026-04-10 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $7.27 | $107K | 444,572 |
| 2026-04-10 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −18,660 | $12.75 | $238K | 425,912 |
| 2026-04-10 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −400 | $13.48 | $5K | 425,512 |
| 2026-04-10 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −14,722 | 8,109 | ||
| 2026-04-09 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +14,722 | $7.27 | $107K | 448,910 |
Page 13 of 119 · 2,375 trades